The inquiry centers on whether the proposed cash-per-share price adequately represents the long-term value of the firm for its investors. Juan Monteverde, lead attorney at the firm, is inviting stockholders to review the terms of the deal to determine if the sale serves their financial interests. The firm, which maintains offices in the Empire State Building, specializes in securities litigation and has previously secured multimillion-dollar recoveries in class action settlements.

Investors holding common stock in Option Care Health can contact the firm to discuss potential concerns regarding the acquisition process. The investigation remains in its early stages, and the firm encourages shareholders to seek independent legal perspective on the transaction’s fairness before the deal proceeds.